{"id":"W4391530349","doi":"10.1001/jamapediatrics.2023.6477","title":"Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"JAMA Pediatrics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sanofi (Canada)","funders":"National Center for Advancing Translational Sciences; Sanofi","keywords":"Alirocumab; Medicine; Dosing; Placebo; Familial hypercholesterolemia; Internal medicine; Pediatrics; Clinical endpoint; Randomized controlled trial; Apolipoprotein B; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004024134,0.0002378589,0.0003869179,0.0004728493,0.00004707348,0.0000976539,0.0001106888,0.0002287487,0.00002044813],"category_scores_gemma":[0.00008967747,0.0001791531,0.0001783262,0.00104376,0.00002328602,0.0002270854,0.00005795489,0.0006404859,0.0001230726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002409633,"about_ca_system_score_gemma":0.0003581859,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001405361,"about_ca_topic_score_gemma":0.00003526963,"domain_scores_codex":[0.9977157,0.00006483678,0.0003736275,0.0004947601,0.0008888885,0.000462201],"domain_scores_gemma":[0.9990715,0.00005914154,0.00004303292,0.0004698815,0.0001180664,0.0002384152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000250274,0.0002657412,0.912407,0.001396308,0.00003711209,0.0005898154,0.0003206138,0.00002009908,0.00000269386,0.00002988365,0.00231031,0.08237018],"study_design_scores_gemma":[0.004311854,0.0005998449,0.9843483,0.00006479049,0.0003649234,0.00005338316,0.00003314267,0.00008269065,0.000006640706,0.00002780865,0.009840719,0.0002659181],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933833,0.003607718,0.0001647489,0.0003611523,0.0005246386,0.0007042069,0.0000290355,0.0001632946,0.001061827],"genre_scores_gemma":[0.9944468,0.001162198,0.000463467,0.0005265119,0.003027035,0.00005121393,0.00007530885,0.00006892409,0.0001785281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08210426,"threshold_uncertainty_score":0.7305651,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007092869066038907,"score_gpt":0.2324196781927528,"score_spread":0.2253268091267139,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}